Stuart Seropian, MD
Associate Professor of Medicine (Hematology); Acting Director, Stem Cell Transplantation; Co-Director, Immune Effector Cell Therapy; Chairman, Car-T Cell Joint Steering Committee; Director, Unrelated Donor Transplant Program, Stem Cell Transplantation
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Education & Training
- MDGeorge Washington University (1991)
- BSTufts University (1984)
- ResidentYale-New Haven Hospital
- InternYale-New Haven Hospital
- Board CertificationAB of Internal Medicine, Medical Oncology (1997, recertified: 2018)
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| Yale Cancer Center Award for Clinical Excellence | Yale Cancer Center | 2016 |
| David S. Fischer Annual Award for Outstanding Teaching and Mentoring of Fellows in Hematology | Yale Cancer Center | 2014 |
| Alpha Omega Alpha Medical Honor Society | AOA | 1991 |
| MD with Distinction, George Washington University School of Medicine | George Washington University School of Medicine | 1991 |
| Horowitz Award, NBME Part I | George Washington University School of Medicine | 1989 |
Professional Service
| Organization | Role | Date |
|---|---|---|
| Hodgkin’s Lymphoma Guidelines Panel, National Comprehensive Cancer Center Network | Committee Member | 2016 - Present |
| Bone Marrow Transplantation | Ad Hoc Reviewer of journal submissions | 2014 - Present |
| EMR User Group, Center for International Blood and Marrow Transplantation Research (CIBMTR) | Member | 2014 - Present |
| Transfusion | Reviewer | 2014 - Present |
| Search Committee, Chair of Pulmonary Section, Department of Medicine | Member | 2008 - 2010 |
| Education Review Committee | Member | 2007 - 2008 |
| Internship Selection Committee | Member | 2006 - 2007 |
| Advisory Board, The Bone Marrow Foundation | Regular participant in public access patient/family online advice query activities. | 2001 - Present |
| Protocol Review Committee | review all clinical research protocols submitted for scientific review in the Cancer Center prior to IRB submission | 1999 - 2017 |